ConTIPI Ltd. (Israel)
Procter & Gamble (PG)
With the support of the BIRD Foundation, Procter & Gamble (PG) collaborated with ConTIPI Ltd. (Israel) to develop a vaginal device for the management of urinary incontinence in women.
Following the conclusion of development and approval of the device for over the counter sales by the U.S. Food and Drug Administration (FDA) in July, 2019, all rights to the device were purchased by Kimberly Clark Worldwide Inc. and is marketed under its Poise® brand.
Approved 2006
